Growth Metrics

Caribou Biosciences (CRBU) Change in Account Payables (2020 - 2025)

Caribou Biosciences has reported Change in Account Payables over the past 6 years, most recently at $1.9 million for Q4 2025.

  • Quarterly Change in Account Payables rose 937.99% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 1019.21% year-over-year, with the annual reading at $3.3 million for FY2025, 1019.21% up from the prior year.
  • Change in Account Payables was $1.9 million for Q4 2025 at Caribou Biosciences, up from $561000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $2.7 million in Q1 2024 and troughed at -$2.4 million in Q2 2024.
  • The 5-year median for Change in Account Payables is $164000.0 (2021), against an average of $156850.0.
  • Year-over-year, Change in Account Payables tumbled 5275.68% in 2022 and then surged 937.99% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $291000.0 in 2021, then tumbled by 152.58% to -$153000.0 in 2022, then skyrocketed by 577.12% to $730000.0 in 2023, then crashed by 131.37% to -$229000.0 in 2024, then surged by 937.99% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Change in Account Payables are $1.9 million (Q4 2025), $561000.0 (Q3 2025), and -$630000.0 (Q2 2025).